The oral cyclophilin inhibitor DEBIO 025 has a "significant antiviral effect" against different genotypes of the hepatitis C virus

Source: Inpharma, Volume 1, Number 1637, 2008-05-10 , pp. 8-8(1)

Publisher: Adis International

Keywords: DEBIO-025, therapeutic use; Hepatitis-C, treatment; HIV-1-infections, treatment; Research-and-development

Document Type: Research article

Publication date: 2008-01-01

• In this: publication
• By this: publisher
• In this Subject: Pharmacology

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers